ArticleThe Journal of pathology2026

Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.

Christoph Steup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.